NTRK2 and Parkinson disease: In line with the protective effect of the TrkB agonist 7,8-DHF in previous AD and PD studies, recent observations demonstrated its protective effects in experimental animal models of 3-NP-induced HD by promoting the activation of CREB and AKT and suppressing neuronal death [168].